Preview: Corvus Pharma's Earnings
Portfolio Pulse from Benzinga Insights
Corvus Pharma (NASDAQ:CRVS) is set to release its latest quarterly earnings report on November 7, 2023. Analysts estimate an EPS of $-0.12. The company's past performance shows a mixed trend of meeting, exceeding, or missing EPS estimates, which has led to varying stock price changes. The company's shares are currently trading at $1.37 and have seen an 83.08% increase over the last 52-week period.
November 06, 2023 | 4:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Corvus Pharma's upcoming earnings report could impact its stock price. The company's past performance shows a mixed trend of meeting, exceeding, or missing EPS estimates, which has led to varying stock price changes. The company's shares are currently trading at $1.37 and have seen an 83.08% increase over the last 52-week period.
The upcoming earnings report is a significant event for Corvus Pharma. The company's past performance shows a mixed trend of meeting, exceeding, or missing EPS estimates, which has led to varying stock price changes. Given the 83.08% increase in the company's shares over the last 52-week period, investors are likely to be watching this earnings report closely.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100